| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P50 | author | Simon Stanworth | Q28036972 |
| P2093 | author name string | Susan J Brunskill | |
| Suzanne M Watt | |||
| Anthony Mathur | |||
| Enca Martin-Rendon | |||
| Chris J Hyde | |||
| P2860 | cites work | The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart | Q58816259 |
| Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 | ||
| Systematic reviews in health care: Assessing the quality of controlled clinical trials | Q29618659 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Primary PCI for myocardial infarction with ST-segment elevation | Q30442496 | ||
| Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction | Q30824170 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Q31113632 | ||
| Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction | Q33273736 | ||
| Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis | Q33285990 | ||
| Bone marrow cells adopt the cardiomyogenic fate in vivo | Q33304156 | ||
| Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group | Q33884453 | ||
| Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function | Q33941111 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed | Q34577274 | ||
| Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines | Q34698821 | ||
| Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). | Q35772741 | ||
| Stem cells and repair of the heart. | Q35832759 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigato | Q46169319 | ||
| Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction | Q48708516 | ||
| Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. | Q50774320 | ||
| Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction | Q51168550 | ||
| Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. | Q51618016 | ||
| Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial | Q56610959 | ||
| P433 | issue | 15 | |
| P921 | main subject | myocardial infarction | Q12152 |
| bone marrow | Q546523 | ||
| systematic review | Q1504425 | ||
| acute myocardial infarction | Q18558122 | ||
| P304 | page(s) | 1807-1818 | |
| P577 | publication date | 2008-06-03 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review | |
| P478 | volume | 29 |
| Q35205665 | "Second-generation" stem cells for cardiac repair |
| Q34116906 | A crucial role of activin A-mediated growth hormone suppression in mouse and human heart failure |
| Q37483053 | A heart full of stem cells: the spectrum of myocardial progenitor cells in the postnatal heart |
| Q45774902 | A new methodological sequence to expand and transdifferentiate human umbilical cord blood derived CD133+ cells into a cardiomyocyte-like phenotype |
| Q37473636 | A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction |
| Q34043802 | Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis |
| Q28082162 | Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials |
| Q37698929 | Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review |
| Q34332004 | Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells |
| Q37536177 | Allogeneic amniotic membrane-derived mesenchymal stromal cell transplantation in a porcine model of chronic myocardial ischemia |
| Q38286293 | An update on primary findings and new designs in biotherapy studies for acute myocardial infarction |
| Q38235169 | An update on stem cell therapies for acute coronary syndrome |
| Q38032602 | Angiogenesis in the infarcted myocardium |
| Q39815712 | Another possible cell source for cardiac regenerative medicine: Reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells |
| Q38938530 | Arrhythmogenesis: a Roadblock to Cardiac Stem Cell Therapy. |
| Q40308084 | Assessment of Myocardial Contractile Function Using Global and Segmental Circumferential Strain following Intracoronary Stem Cell Infusion after Myocardial Infarction: MRI Feature Tracking Feasibility Study |
| Q39514108 | At a crossroad: cell therapy for cardiac repair |
| Q34614528 | Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells |
| Q37942600 | Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta-analysis of randomized controlled trials |
| Q42316372 | Autologous c-Kit+ Mesenchymal Stem Cell Injections Provide Superior Therapeutic Benefit as Compared to c-Kit+ Cardiac-Derived Stem Cells in a Feline Model of Isoproterenol-Induced Cardiomyopathy |
| Q42727661 | Biology of stem cells: an overview |
| Q53065775 | Bone Marrow Cell Transplant From Donors With Cardiovascular Risk Factors Increases the Pro-atherosclerotic Phenotype in the Recipients. |
| Q37783801 | Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy |
| Q53316434 | Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). |
| Q90183606 | Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN |
| Q27006710 | Bone marrow mononuclear cells and acute myocardial infarction |
| Q37194005 | Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction. |
| Q37951953 | Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. |
| Q41864154 | CD45-CD14 +CD34 + murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation potential in long-term in vitro culture |
| Q57951477 | COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients After Acute Myocardial Infarction and Left Ventricular Dysfunction: Study Rationale and Design |
| Q51354259 | Cardiac Telocytes in Regeneration of Myocardium After Myocardial Infarction. |
| Q37371934 | Cardiac cell repair therapy: a clinical perspective |
| Q37800141 | Cardiac cell therapies: the next generation |
| Q37769840 | Cardiac cell therapy: lessons from clinical trials |
| Q35144550 | Cardiac cell therapy: where we've been, where we are, and where we should be headed |
| Q87847444 | Cardiac mesenchymal progenitors from postmortem cardiac tissues retained cellular characterization |
| Q38079141 | Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research |
| Q37866145 | Cardiac regeneration: different cells same goal |
| Q33406980 | Cardiac repair with adult bone marrow-derived cells: the clinical evidence |
| Q38030877 | Cardiac stem cells in patients with ischemic cardiomyopathy: discovery, translation, and clinical investigation |
| Q42914114 | Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts |
| Q34063589 | Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks--an MRI study |
| Q40660723 | Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials |
| Q38714410 | Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews |
| Q38226693 | Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences. |
| Q35923395 | Cell therapy for refractory angina: time for more ACTion |
| Q37696967 | Cell therapy for the treatment of coronary heart disease: a critical appraisal |
| Q37388609 | Cell therapy with bone marrow cells for myocardial regeneration |
| Q36784068 | Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network |
| Q35589728 | Cell tracking in cardiac repair: what to image and how to image. |
| Q82470535 | Cell treatment after acute myocardial infarction prevents early decline in circulating IGF-1 |
| Q33713519 | Cell-based therapy for heart disease: a clinically oriented perspective |
| Q36628329 | Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors |
| Q33582866 | Circulating endothelial progenitor cells: a new approach to anti-aging medicine? |
| Q34786321 | Clinical trials of cardiac repair with adult bone marrow- derived cells |
| Q37099897 | Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model. |
| Q36578130 | Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction |
| Q36736372 | Complete cardiac regeneration in a mouse model of myocardial infarction |
| Q52690932 | Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future. |
| Q38063849 | Concise review: cell therapy and tissue engineering for cardiovascular disease |
| Q37056280 | Concise review: the role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy |
| Q38697092 | Current State of Stem Cell Therapy for Ischemic Heart Disease |
| Q38090542 | Current status of cell-based therapy for heart failure |
| Q35623878 | Current status of stem cell therapy in heart failure |
| Q37789521 | Current status of the role of stem cells in myocardial biology and repair |
| Q34510325 | Density gradient centrifugation compromises bone marrow mononuclear cell yield |
| Q91631526 | Design and Validation of an Automated Process for the Expansion of Peripheral Blood-Derived CD34+ Cells for Clinical Use After Myocardial Infarction |
| Q33745962 | Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial. |
| Q36721861 | Differentiation of Enhanced Green Fluorescent Protein-Labeled Mouse Amniotic Fluid-Derived Stem Cells into Cardiomyocyte-Like Beating Cells. |
| Q30541092 | Direct reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogels |
| Q47573004 | Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarction. |
| Q35802937 | Dual isotope simultaneous imaging to evaluate the effects of intracoronary bone marrow-derived mesenchymal stem cells on perfusion and metabolism in canines with acute myocardial infarction |
| Q57911490 | EPO's rescue mission in acute myocardial infarction: still more hopes than evidence |
| Q34074673 | Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial |
| Q54260835 | Effect of the stop-flow technique on cardiac retention of c-kit positive human cardiac stem cells after intracoronary infusion in a porcine model of chronic ischemic cardiomyopathy. |
| Q36694346 | Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial |
| Q33590936 | Effects of stem cell therapy on left ventricular remodeling after acute myocardial infarction: a meta-analysis. |
| Q42689817 | Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials |
| Q33607929 | Efficacy and safety of intracoronary autologous bone marrow-derived cell transplantation in patients with acute myocardial infarction: insights from randomized controlled trials with 12 or more months follow-up. |
| Q34241616 | Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. |
| Q96231581 | Electrically stimulable indium tin oxide plate for long-term in vitro cardiomyocyte culture |
| Q47890976 | Emerging Therapies for Congestive Heart Failure |
| Q36657651 | Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps |
| Q36991096 | Endothelial progenitor cell: a blood cell by many other names may serve similar functions |
| Q34444790 | Endothelial progenitor cells as factors in neovascularization and endothelial repair |
| Q37776785 | Endothelial progenitor cells: Quo Vadis? |
| Q37325660 | Endothelial progenitor cells: implications for cardiovascular disease |
| Q26796330 | Endpoints in stem cell trials in ischemic heart failure |
| Q38175899 | Engineering the extracellular matrix for clinical applications: endoderm, mesoderm, and ectoderm |
| Q34055868 | Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix |
| Q96132624 | Exosomal lncRNA AK139128 Derived from Hypoxic Cardiomyocytes Promotes Apoptosis and Inhibits Cell Proliferation in Cardiac Fibroblasts |
| Q37918523 | Extracorporeal shock wave therapy for ischemic cardiovascular disorders |
| Q29994502 | Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction |
| Q85101604 | Functional Recovery Following Intracoronary Infusion of Autologous Mononuclear Bone Marrow Cells in Patients With Chronic Anterior Myocardial Infarction and Severely Depressed Ventricular Function |
| Q35539690 | Functional and transcriptomic recovery of infarcted mouse myocardium treated with bone marrow mononuclear cells. |
| Q37311008 | GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy |
| Q26865425 | Gene and cell therapies for the failing heart to prevent sudden arrhythmic death |
| Q26774939 | How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart? |
| Q97646321 | Human MuStem Cell Grafting into Infarcted Rat Heart Attenuates Adverse Tissue Remodeling and Preserves Cardiac Function |
| Q34333348 | Human endothelial stem/progenitor cells, angiogenic factors and vascular repair |
| Q37970120 | Human spermatagonial stem cells: a novel therapeutic hope for cardiac regeneration and repair? |
| Q33746675 | Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms |
| Q26771257 | Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis |
| Q55040403 | Impact of bone marrow mononuclear cells therapy on left ventricular function in patients with ST-elevated myocardial infarction: A meta-analysis. |
| Q34879592 | Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction ( |
| Q27001633 | Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis |
| Q39018495 | Impaired redox environment modulates cardiogenic and ion-channel gene expression in cardiac-resident and non-resident mesenchymal stem cells |
| Q33981146 | Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRN |
| Q64946838 | Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction. |
| Q50625476 | In vivo MRI mapping of iron oxide-labeled stem cells transplanted in the heart. |
| Q46232303 | In-vivo comparison of the acute retention of stem cell derivatives and fibroblasts after intramyocardial transplantation in the mouse model |
| Q33733431 | Incidence of ventricular arrhythmias after stem cell therapy in patients with Chagas cardiomyopathy |
| Q42280387 | Inhibition of apoptosis by knockdown of caspase-3 with siRNA in rat bone marrow mesenchymal stem cells. |
| Q30571628 | Injectable hydrogel as stem cell scaffolds from the thermosensitive terpolymer of NIPAAm/AAc/HEMAPCL |
| Q33762062 | Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial |
| Q34318046 | Intracoronary delivery of bone-marrow-derived stem cells |
| Q59260969 | Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled |
| Q51746115 | Intramuscular Transplantation of Pig Amniotic Fluid-Derived Progenitor Cells Has Therapeutic Potential in a Mouse Model of Myocardial Infarction. |
| Q33991604 | Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted cardiac function in rats. |
| Q54089088 | Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction. |
| Q36841242 | Isolation, identification, and comparison of cartilage stem progenitor/cells from auricular cartilage and perichondrium |
| Q33531541 | Lasers, stem cells, and COPD. |
| Q34090699 | LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction |
| Q34288961 | Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes |
| Q37305343 | Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up |
| Q42409098 | Low connexin channel-dependent intercellular communication in human adult hematopoietic progenitor/stem cells: probing mechanisms of autologous stem cell therapy |
| Q52730314 | Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis. |
| Q46374324 | Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction |
| Q44069868 | Mesenchymal stem cell transplantation mitigates electrophysiological remodeling in a rat model of myocardial infarction. |
| Q37982370 | Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap |
| Q35196281 | Mesenchymal stem cells from fetal heart attenuate myocardial injury after infarction: an in vivo serial pinhole gated SPECT-CT study in rats |
| Q41117181 | Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics. |
| Q34575909 | Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist--an initial in vitro study. |
| Q36807360 | Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies: Controversies in Meta-Analyses Results on Cardiac Cell-Based Regenerative Studies |
| Q35219587 | Meta-analysis of the effect of mesenchymal stem cell transplantation on vascular remodeling after carotid balloon injury in animal models |
| Q35866749 | MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5/cyclin D1 signaling |
| Q38045804 | Myocardial regeneration of the failing heart |
| Q35778889 | Myocardial restoration: is it the cell or the architecture or both? |
| Q33746524 | Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction |
| Q41573826 | Neural Crest Stem Cells Can Differentiate to a Cardiomyogenic Lineage with an Ability to Contract in Response to Pulsed Infrared Stimulation |
| Q48762293 | Noninvasive in vivo tracking of mesenchymal stem cells and evaluation of cell therapeutic effects in a murine model using a clinical 3.0 T MRI. |
| Q37792416 | Novel Therapies in Childhood Heart Failure: Today and Tomorrow |
| Q38801590 | Novel cardioprotective and regenerative therapies in acute myocardial infarction: a review of recent and ongoing clinical trials |
| Q38803500 | One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133 Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction. |
| Q38982831 | Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology |
| Q35169966 | Oversight and management of a cell therapy clinical trial network: experience and lessons learned |
| Q37769841 | Oxygen and oxygenation in stem-cell therapy for myocardial infarction |
| Q36739728 | Pericytes from human veins for treatment of myocardial ischemia |
| Q38050930 | Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review |
| Q51778384 | Phases I-III Clinical Trials Using Adult Stem Cells. |
| Q37016190 | Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure |
| Q43964974 | Potential Role of Exosomes in Mending a Broken Heart: Nanoshuttles Propelling Future Clinical Therapeutics Forward. |
| Q37735796 | Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review |
| Q27012551 | Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease |
| Q92351043 | Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure |
| Q38384991 | PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. |
| Q37802573 | Preclinical and Clinical Studies on Application of Human Myoblasts in Regeneration of the Postinfarction Heart |
| Q33661061 | Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trial. |
| Q26782465 | Priming the Surface of Orthopedic Implants for Osteoblast Attachment in Bone Tissue Engineering |
| Q36848798 | Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells |
| Q49288386 | Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease. |
| Q92786478 | Randomised, double-blind, placebo-controlled clinical trial for evaluating the efficacy of intracoronary injection of autologous bone marrow mononuclear cells in the improvement of the ventricular function in patients with idiopathic dilated myocard |
| Q34544884 | Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity |
| Q36262927 | Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials |
| Q37444118 | Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction |
| Q47642528 | Recent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology. |
| Q36038854 | Regeneration of the heart |
| Q33687920 | Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction |
| Q35140094 | Reversal of ischemic cardiomyopathy with Sca-1+ stem cells modified with multiple growth factors |
| Q33753657 | Review article: current status of myocardial regeneration: new cell sources and new strategies |
| Q33490304 | Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease |
| Q47347279 | Short- and long-term outcomes of intramyocardial implantation of autologous bone marrow-derived cells for the treatment of ischaemic heart disease |
| Q38466418 | Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials |
| Q48083777 | Stem Cell Therapy and Congenital Heart Disease |
| Q85240790 | Stem and progenitor cell-based therapy approaches: current developments on treatment of acute myocardial infarction and chronic ischemic cardiomyopathy |
| Q34981433 | Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges |
| Q34988926 | Stem cell labeling for noninvasive delivery and tracking in cardiovascular regenerative therapy |
| Q37395901 | Stem cell researches in Brazil: present and future challenges |
| Q42575207 | Stem cell therapy and regenerative medicine |
| Q37827158 | Stem cell therapy for cardiac disease. |
| Q34129904 | Stem cell therapy for cardiac dysfunction |
| Q36836349 | Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology |
| Q24194988 | Stem cell therapy for chronic ischaemic heart disease and congestive heart failure |
| Q37877423 | Stem cell therapy for heart diseases |
| Q24240357 | Stem cell therapy for ischaemic heart disease and congestive heart failure |
| Q37651897 | Stem cell therapy in acute myocardial infarction: a review of clinical trials |
| Q37945676 | Stem cell therapy in cardiology |
| Q38077116 | Stem cell therapy: promising treatment in heart failure? |
| Q55087466 | Stem cell transplantation dose in patients with acute myocardial infarction: A meta-analysis. |
| Q24186920 | Stem cell treatment for acute myocardial infarction |
| Q24203736 | Stem cell treatment for acute myocardial infarction |
| Q38124263 | Stem cells for cardiac repair: an introduction |
| Q38063950 | Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome? |
| Q84442555 | Stem cells: REGENT trial-the end of cell therapy for MI? |
| Q38467240 | Stem-cell angiogenesis and regeneration of the heart: review of a saga of 2 decades. |
| Q39964488 | Stem/Progenitor cells, atherosclerosis and cardiovascular regeneration |
| Q90481092 | Stemness and Regenerative Potential of Corneal Stromal Stem Cells and Their Secretome After Long-Term Storage: Implications for Ocular Regeneration |
| Q38553350 | The Role of Synthetic Extracellular Matrices in Endothelial Progenitor Cell Homing for Treatment of Vascular Disease |
| Q45875475 | The TIME Trial - Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis |
| Q36836344 | The birth of 'regenerative pharmacology': a clinical perspective |
| Q55415942 | The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016. |
| Q38210142 | The current landscape of adipose-derived stem cells in clinical applications |
| Q35079018 | The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion. |
| Q49833909 | The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial. |
| Q37372331 | The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction |
| Q37625460 | The existence of myocardial repair: mechanistic insights and enhancements |
| Q37910044 | The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine |
| Q34008284 | The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature |
| Q37815453 | The role of cardiac electrophysiology in myocardial regenerative stem cell therapy |
| Q35654823 | The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor |
| Q28247457 | The stuttering progress of cell therapy for heart disease |
| Q39580194 | The use of stem cells for the repair of cardiac tissue in ischemic heart disease |
| Q59047223 | Total Ischemic Time as an Independent Predictor of Response to Stem Cell Therapy in Patients with ST Segment Elevation Myocardial Infarction |
| Q30736517 | Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data. |
| Q42558457 | Tracking cell fate with noninvasive imaging |
| Q35995055 | Translational aspects of cardiac cell therapy |
| Q52963392 | Transplantation of adipose tissue-derived stem cells improves cardiac contractile function and electrical stability in a rat myocardial infarction model. |
| Q46143918 | Update on interventional cardiology |
| Q37957060 | Using biomaterials to improve the efficacy of cell therapy following acute myocardial infarction |
| Q53486196 | Uterine cells-an immunoprivileged cell source for therapy-but are they for everyone? |
| Q39325172 | What is wrong with meta-analysis? The importance of clinical heterogeneity in myocardial regeneration research |
| Q38034130 | What's new in regenerative medicine: split up of the mesenchymal stem cell family promises new hope for cardiovascular repair. |
| Q83832984 | [Cell therapy for acute myocardial infarction] |
| Q27315833 | c-kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signalling |
Search more.